Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/10/2026

Weaning from Mechanical Ventilation

Spontaneous Breathing Trials (SBTs)

  • The American College of Chest Physicians/American Thoracic Society guidelines suggest that initial SBT be conducted with modest inspiratory pressure augmentation (5-8 cm H₂O) rather than T-piece 1
  • SBTs are the gold standard approach for assessing extubation readiness and should be performed daily in patients who meet readiness criteria 2
  • SBTs can be conducted using low-level pressure support ventilation (5-8 cm H₂O) 3, 1
  • Most SBT failures occur within the first 30 minutes of the trial 2, 1

Pressure Support Ventilation (PSV) and Synchronized Intermittent Mandatory Ventilation (SIMV)

  • The American Thoracic Society and European Respiratory Society state that SIMV is inferior to PSV and T-piece weaning 4

Comparison of Weaning Methods

  • SBTs conducted with pressure augmentation (CPAP) are more likely to be successful than T-piece trials, with higher rates of extubation success (75.4% vs 68.9%) 1
  • For patients at high risk of extubation failure, T-piece trials may be more specific (though less sensitive) in identifying patients truly ready for extubation 1

Newer Approaches to Weaning

  • Noninvasive positive pressure ventilation (NIV) after extubation is recommended for patients at high risk for extubation failure 5
  • For patients with high risk of lung collapse (e.g., morbid obesity or after cardiac surgery), direct extubation from CPAP levels ≥10 cmH₂O has been used successfully 5

Classification of Weaning

  • Patients can be categorized into three groups based on the difficulty and duration of the weaning process: simple weaning, difficult weaning, and prolonged weaning 5, 1
  • Simple weaning: patients who successfully pass the first SBT and are extubated on the first attempt (up to 70% of ICU patients) 5, 1
  • Difficult weaning: patients who require up to three SBTs or up to 7 days from the first SBT to achieve successful weaning (approximately 15% of patients) 5
  • Prolonged weaning: patients who require more than three SBTs or >7 days of weaning after the first SBT (approximately 15% of patients) 5

Weaning Protocols and Assessment

  • Daily assessment of readiness for weaning should be performed using standardized protocols 4, 2
  • A successful SBT does not guarantee successful extubation - approximately 10% of patients who pass an SBT will still fail extubation 1

Weaning from Mechanical Ventilation

Key Predictors and Weaning Methods

  • The European Respiratory Society recommends a systematic screening approach for weaning, including a PaO₂/FiO₂ ratio ≥ 200, PEEP ≤ 5 cm H₂O, RSBI ≤ 105 breaths/min/L, intact cough on suctioning, and absence of sedative or vasopressor infusions 6
  • Non-invasive ventilation (NIV) can facilitate weaning in patients with hypercapnic respiratory failure, especially those with COPD, with decreased mortality (RR 0.54, 95% CI 0.41-0.70) and reduced weaning failure (RR 0.61, 95% CI 0.48-0.79) 6
  • NIV use for weaning in hypercapnic respiratory failure has shown a lower incidence of ventilator-associated pneumonia (RR 0.22, 95% CI 0.15-0.32) 7

Weaning Protocol Implementation

  • The Society of Critical Care Medicine strongly recommends using a weaning protocol with SBTs (high quality evidence) 7
  • Mechanically ventilated patients with sepsis who can tolerate weaning should use a weaning protocol (strong recommendation, moderate quality evidence) 7

Weaning Protocol for Intubated Patients

Initial Spontaneous Breathing Trial Parameters

  • The American Thoracic Society recommends setting PEEP at ≤5 cm H₂O during the spontaneous breathing trial (SBT) 8
  • FiO2 should be maintained at 40% or lower during the SBT 8

Monitoring During the SBT

  • Respiratory rate >35 breaths/min or increasing trend is an indicator of SBT failure 9
  • SpO2 <90% is an indicator of SBT failure 8, 10
  • Heart rate >140 bpm or sustained increase >20% is an indicator of SBT failure 8
  • Systolic blood pressure >180 mmHg or <90 mmHg is an indicator of SBT failure 8
  • Increased anxiety or diaphoresis is an indicator of SBT failure 8
  • Use of accessory muscles or abdominal paradox is an indicator of SBT failure 8

Extubation Decision

  • For standard-risk patients, extubate directly to supplemental oxygen via face mask or nasal cannula, targeting SpO2 88-92% 11, 8, 10
  • For high-risk patients, consider extubation directly to noninvasive positive pressure ventilation (NIV) 11

Post-Extubation Management

  • Use supplemental oxygen cautiously, particularly in patients with chronic hypercapnia, to avoid correcting hypoxemia without treating underlying hypoventilation or atelectasis 11, 12
  • Monitor SpO2, targeting 88-92%, and respiratory rate and work of breathing continuously for the first 24 hours 8, 10, 9

Alternative Approach: Direct Extubation to NIV

  • For patients with chronic respiratory disease, consider systematic extubation to NIV, starting with IPAP at 10-12 cm H₂O and EPAP at 5-10 cm H₂O 8, 10
  • Titrate FiO2 to maintain SpO2 88-92% during NIV 8, 10

Difficult Weaning from Mechanical Ventilation

Pathophysiologic Mechanisms

  • Respiratory or global muscle weakness, including diaphragmatic dysfunction, can occur during difficult weaning from mechanical ventilation, according to the American Thoracic Society 13

Clinical Implications

  • The European Society of Intensive Care Medicine recommends that therapist-driven weaning protocols should be implemented and strictly adhered to for critically ill patients with COPD, pneumonia, and ARDS experiencing difficult weaning 14
  • Non-invasive ventilation (NIV) may facilitate weaning in hypercapnic patients, particularly those with COPD, with a demonstrated mortality reduction, as suggested by the American College of Chest Physicians 14

Weaning from Mechanical Ventilation

Readiness Criteria

  • The American Thoracic Society and other medical societies recommend that patients meet specific criteria before initiating weaning, including resolution or significant improvement of the primary condition that necessitated mechanical ventilation, hemodynamic stability without vasopressor agents, and patient arousability with absence of heavy sedation 15
  • The Surviving Sepsis Campaign strongly recommends using spontaneous breathing trials in mechanically ventilated patients with sepsis who are ready for weaning, as this approach has significantly higher success rates 15

The Weaning Process

  • The use of pressure support ventilation (5-8 cm H₂O) rather than T-piece for the initial spontaneous breathing trial is recommended, as this approach has significantly higher success rates (84.6% vs 76.7%) 15
  • The duration of the spontaneous breathing trial should be 30 minutes for standard-risk patients and 60-120 minutes for high-risk patients, as most failures occur within the first 30 minutes 15

Post-Extubation Management

  • For high-risk patients, prophylactic noninvasive positive pressure ventilation immediately after extubation has demonstrated decreased mortality (RR 0.54, 95% CI 0.41-0.70) and reduced weaning failure (RR 0.61, 95% CI 0.48-0.79), although the specific citation for this is not provided in the original text, it is implied to be related to 15

Approach to Weaning from Mechanical Ventilation

Daily Readiness Assessment

  • The American College of Chest Physicians recommends that patients meet all of the following criteria to be considered ready for weaning: arousable, hemodynamically stable, resolution or significant improvement of the primary condition requiring mechanical ventilation, adequate oxygenation, low ventilatory requirements, rapid shallow breathing index (RSBI) ≤105 breaths/min/L, and intact cough on suctioning with minimal secretions or effective clearance mechanism, particularly in patients over 65 years with multiple comorbidities 16

Special Considerations for Sepsis Patients

  • The Surviving Sepsis Campaign strongly recommends using spontaneous breathing trials in mechanically ventilated sepsis patients who meet readiness criteria (strong recommendation, high quality evidence) 16
  • The Surviving Sepsis Campaign recommends using a weaning protocol in sepsis-induced respiratory failure patients who can tolerate weaning (strong recommendation, moderate quality evidence) 16
  • The American College of Chest Physicians recommends maintaining head of bed elevation between 30-45 degrees throughout the weaning process to limit aspiration risk and prevent ventilator-associated pneumonia 16

Critical Pitfalls to Avoid

  • The American College of Chest Physicians recommends avoiding premature weaning in patients still requiring vasopressors or with unresolved primary pathology 16

Weaning Assessment Criteria Supported by Evidence

Rapid Shallow Breathing Index (RSBI)

  • Measure the rapid shallow breathing index after 30–60 minutes of spontaneous breathing during a spontaneous breathing trial to evaluate readiness for extubation. 17

Oxygenation Threshold for Initiating Weaning

  • Do not commence weaning when PaO₂ < 55 mm Hg on FiO₂ ≥ 0.40, as the probability of weaning failure is markedly increased. 17

Protocol‑Driven Weaning Improves Clinical Outcomes

Implementation of a Daily Standardized Weaning Protocol

  • A daily standardized weaning protocol that uses spontaneous breathing trials (SBTs) with pressure‑support ventilation set to 5–8 cm H₂O (instead of a T‑piece) increases SBT success rates (84.6 % vs 76.7 %) and shortens the overall duration of mechanical ventilation in adult ICU patients. 18

Effects on Mechanical Ventilation Duration

  • Protocol‑driven weaning reduces the total time a patient remains on mechanical ventilation by approximately 25 hours compared with physician‑judgment‑only approaches. 18

Effects on ICU Length of Stay

  • Implementing a protocolized weaning strategy shortens ICU length of stay by about 1 day relative to non‑protocolized care. 18
  • The weaning protocol should be carried out by respiratory therapists or nurses, with physician approval required only for the final extubation decision. 18

Rapid Shallow Breathing Index (RSBI) for Weaning from Mechanical Ventilation

RSBI Thresholds for Decision‑Making

  • An RSBI ≤ 105 breaths/min/L is an acceptable ventilatory requirement to proceed with a spontaneous breathing trial (SBT). 19
  • An RSBI < 80 breaths/min/L increases the likelihood of successful weaning by ~7.5‑fold, representing a strong positive predictor. 19
  • An RSBI > 100 breaths/min/L reduces the probability of successful weaning to 0.04, indicating a strong negative predictor. 19

Measurement Technique

  • RSBI should be measured after 30–60 minutes of spontaneous breathing, not during the first minute when respiratory drive may still be suppressed. 19
  • The measurement is performed with a handheld spirometer attached to the endotracheal tube while the patient breathes spontaneously for 1 minute. 19

Predictive Performance

  • RSBI shows superior discriminative power with an area under the ROC curve of 0.89, compared with:
    • Minute ventilation (AUC 0.40)
    • PaO₂/PAO₂ ratio (AUC 0.48)
    • Maximal inspiratory pressure (AUC 0.61)

Guidelines for Liberation from Mechanical Ventilation

Spontaneous Breathing Trial (SBT) Protocol

  • Using pressure‑support ventilation set at 5–8 cm H₂O with PEEP 5 cm H₂O for the initial SBT increases the probability of SBT success from 76.7 % to 84.6 % and extubation success from 68.9 % to 75.4 % in standard‑risk patients. [20][21]

Identification of High‑Risk Patients for Extubation Failure

  • Patients are considered high‑risk for extubation failure when any of the following are present:

Post‑Extubation Prophylactic Strategies

  • Prophylactic non‑invasive ventilation (NIV) applied within 1 hour after extubation in high‑risk patients reduces:

  • High‑flow nasal cannula (HFNC) as an alternative to conventional oxygen therapy lowers re‑intubation rates to 4 % versus 21 % (P = 0.01). [20][21]

  • In patients who are hypercapnic during the SBT (PaCO₂ > 45 mm Hg), prophylactic NIV further reduces 90‑day mortality (RR = 0.58; 95 % CI 0.27–1.22). [20][21]

Avoidance of Unnecessary Delays in Low‑Risk Patients

  • Extubation should not be delayed in patients who pass their first SBT, are < 65 years, have normal PaCO₂, and lack significant respiratory or cardiac comorbidities, because they rarely require prophylactic NIV. [20][21]

Evidence‑Based Strategies for Weaning from Mechanical Ventilation

1. Protocolized Weaning Approach

2. Daily Readiness Assessment

3. Conducting the Spontaneous Breathing Trial (SBT)

4. Identification of High‑Risk Patients for Extubation Failure

Risk Factor (generic) Evidence Source
Age > 65 years [24]
Primary cardiac failure as cause of respiratory failure [24]
Failure of more than one prior SBT [24]
Presence of ≥ 1 comorbid condition (e.g., chronic obstructive pulmonary disease, congestive heart failure) [24]

5. Protocol‑Driven Implementation

6. Sepsis‑Specific Recommendations

7. Definition of Extubation Success

Evidence‑Based Weaning and Extubation Protocol for Adult Patients on Invasive Mechanical Ventilation

1. Daily Readiness Screening

2. Spontaneous Breathing Trial (SBT) Technique

3. Identification of High‑Risk Patients for Extubation

4. Extubation Strategies for High‑Risk Patients

5. Standard‑Risk Extubation

All facts above are derived from the 2017 Chest guideline and are supported by the cited evidence.

Daily Sedation Minimization Improves Ventilator Outcomes

Sedation Management

Evidence‑Based Guidelines for Liberation from Mechanical Ventilation

1. Readiness Criteria (Anaesthesia 2017 guideline)

  • A patient is considered ready for weaning when the underlying reversible illness has resolved or markedly improved. 27
  • The patient must be awake and able to protect the airway. 27
  • A positive cuff‑leak test indicates adequate upper‑airway patency and lowers the risk of post‑extubation stridor. [28][29]

2. Spontaneous Breathing Trial (SBT)

  • The 2017 Anaesthesia guideline strongly recommends performing an SBT before any extubation in ICU patients who have been mechanically ventilated for more than 48 hours. 27

3. Extubation Decision

  • An extubation failure rate of 5 %–10 % is considered acceptable in contemporary practice. [28][29]
  • Approximately 10 % of patients who successfully complete an SBT will still fail extubation; this rate is regarded as normal and does not imply inadequate assessment. [28][29]

4. High‑Risk Features for Extubation Failure

High‑Risk Feature Relevance
Weak cough or excessive secretions Increases likelihood of extubation failure and warrants consideration of prophylactic non‑invasive ventilation. [28][29]
Age > 65 years with multiple comorbidities Identified as a high‑risk criterion (not present in the current patient).
Cardiac failure as primary cause of respiratory failure High‑risk criterion (not present).
Failure of more than one prior SBT High‑risk criterion (not present).
Post‑extubation PaCO₂ > 45 mm Hg High‑risk criterion (not present).

5. Cuff‑Leak Test Recommendations

  • A positive cuff‑leak test markedly reduces the risk of post‑extubation stridor, which is responsible for roughly 15 % of early re‑intubations. [28][29]
  • The cuff‑leak test should be performed in any patient with risk factors for laryngeal edema, including female gender, nasal intubation, difficult or traumatic intubation, use of a large end‑tracheal tube, or high cuff pressures. [28][29]

6. Guideline Summary (Anaesthesia Society, 2017)

  • Protocol‑driven weaning, incorporating a pressure‑support SBT and systematic assessment of risk factors, is endorsed to optimize timing of extubation.
  • While the SBT is essential, it alone cannot identify all patients at risk of failure; therefore, screening for specific risk factors (upper‑airway obstruction, ineffective cough, excessive secretions, swallowing disorders, altered consciousness) is mandatory. [27][28]29

Strength of evidence: All statements are derived from the 2017 Anaesthesia clinical practice guideline, which provides a Class I recommendation for performing an SBT before extubation in ventilated ICU patients.

Absence of New Serious Conditions or Planned Procedures in the Next 12–24 Hours

Daily Readiness Assessment

  • For hemodynamically stable adults who meet standard readiness criteria, the presence of no new potentially serious conditions and no planned procedures within the upcoming 12–24 hours is required before initiating a weaning attempt. This criterion helps ensure patient stability during spontaneous breathing trials and reduces the risk of extubation failure. 30

Guideline Recommendations for Prolonged Mechanical Ventilation

Ventilation Mode Selection

  • For adult patients who have been mechanically ventilated for more than 7 days, synchronized intermittent mandatory ventilation (SIMV) is inferior to assist‑control ventilation and should not be used as the primary weaning mode; initiate assist‑control and then transition to daily spontaneous breathing trials (SBTs) with pressure support of 5–8 cm H₂O. [Intensive Care Medicine, 2001] 31
  • No ventilation mode has demonstrated a mortality benefit in respiratory failure, but assist‑control provides full ventilatory support and is appropriate at the start of mechanical ventilation. [Intensive Care Medicine, 2001] 31

Initial Ventilation Settings (Days 1–7)

  • Begin volume‑cycled assist‑control ventilation to ensure complete respiratory support and optimal redistribution of cardiac output to vital organs. [Intensive Care Medicine, 2001] 31
  • Apply low tidal volumes of 4–8 mL per kg predicted body weight and keep plateau pressures below 30 cm H₂O to minimize ventilator‑induced lung injury. [American Journal of Respiratory and Critical Care Medicine, 2017] 32

Protocolized Weaning Strategy (After Day 7)

  • Use a protocolized weaning approach that incorporates daily readiness screening and SBTs rather than gradual SIMV weaning. [American Journal of Respiratory and Critical Care Medicine, 2017] 33

Spontaneous Breathing Trial (SBT) Parameters

  • Conduct SBTs with pressure support of 5–8 cm H₂O plus 5 cm H₂O PEEP; this method raises SBT success from ~77 % to ~85 % and extubation success from ~69 % to ~75 %. [American Journal of Respiratory and Critical Care Medicine, 2017] 33
  • Standard‑risk patients should undergo a 30‑minute SBT, while high‑risk patients may require 60–120 minutes, as most failures occur within the first 30 minutes. [American Journal of Respiratory and Critical Care Medicine, 2017] 33
  • The SBT‑based weaning approach is supported by moderate‑quality evidence, whereas head‑to‑head trials show SIMV to be inferior. [American Journal of Respiratory and Critical Care Medicine, 2017] 33

Post‑Extubation Management for High‑Risk Patients

  • Identify high‑risk individuals (older adults, chronic lung or heart disease, hypercapnia during SBT, prolonged ventilation >14 days, ineffective cough) and extubate them directly to prophylactic non‑invasive ventilation (NIV). [American Journal of Respiratory and Critical Care Medicine, 2017] 33
  • For high‑risk patients with prolonged intubation (>7 days), perform a cuff‑leak test and, if the test fails, administer systemic steroids at least 4 hours before extubation. [American Journal of Respiratory and Critical Care Medicine, 2017] 33

Evidence‑Based Pressure Support Ventilation Settings for Weaning

Ventilator Parameter Settings for Spontaneous Breathing Trials

  • Conduct SBTs with pressure support 5–8 cm H₂O and PEEP 5 cm H₂O; this increases SBT success from 77 % to 85 % and extubation success from 69 % to 75 % compared with T‑piece trials【34】.
  • Use a modest pressure‑support level (5–8 cm H₂O) to overcome end‑tracheal‑tube resistance without masking readiness for weaning【34】.
  • Set PEEP at 5 cm H₂O during the SBT; PEEP maintains alveolar recruitment and reduces work of breathing from intrinsic PEEP in obstructive disease【34】【35】.
  • Maintain FiO₂ ≤ 0.40 (40 %) throughout the SBT【34】.
  • Titrate FiO₂ to achieve SpO₂ 90–96 % in most patients【36】【37】; for patients with chronic hypercapnia, target SpO₂ 88–92 %【37】.

Trigger and Cycling Settings

  • Set flow‑trigger sensitivity to 1–3 L/min for optimal patient‑ventilator synchrony【35】.
  • If flow triggering is unavailable, use pressure triggering of ‑0.5 to ‑2 cm H₂O【35】.
  • Proper trigger sensitivity is essential to minimize work of breathing and prevent dyssynchrony【35】.
  • Use an expiratory cycling threshold of 25 % of peak inspiratory flow for most patients; increase to 40 % in obstructive lung disease to avoid auto‑PEEP【35】, while 25 % remains appropriate for restrictive disease【35】.
  • Set rise time (pressurization rate) to 0.1–0.2 s for the majority of patients【35】; faster rise times improve comfort in high‑drive patients, whereas slower rise times are advisable in COPD to prevent pressure overshoot【35】.

Alarm and Monitoring Parameters

  • Configure the apnea alarm to trigger after 20 seconds of no airflow【35】.
  • Set the low‑SpO₂ alarm threshold at < 90 %【34】.
  • Continuously monitor pressure‑time and flow‑time scalars to assess synchrony【35】.
  • Close observation during the first 1–2 hours of the trial is critical; delayed recognition of failure increases the risk of re‑intubation【36】【37】.

Risks of Inappropriate Settings

  • Applying pressure support > 8 cm H₂O during the final SBT can mask inadequate respiratory muscle strength and lead to extubation failure【34】.
  • If a backup respiratory rate is required during PSV weaning trials, the patient is not yet ready for weaning【37】.

All facts are derived from peer‑reviewed sources (Chest 2017; Intensive Care Medicine 2017; International Journal of Infectious Diseases 2021) and reflect the current evidence base for pressure‑support ventilation during weaning.

Evidence‑Based Extubation and Weaning Guidelines for Adult ICU Patients

1. Daily Readiness Screening

  • Adult ICU patients should be assessed daily and must demonstrate resolution or marked improvement of the condition that required mechanical ventilation and hemodynamic stability (no active myocardial ischemia and minimal or no vasopressor support) before any weaning attempt is made. 38

2. Spontaneous Breathing Trial (SBT) Settings

  • The initial SBT should be performed using pressure‑support ventilation (PSV) rather than a T‑piece, with pressure support of 5–8 cm H₂O and PEEP of 5 cm H₂O. 38

3. Preferred Weaning Mode

  • Pressure‑support ventilation is recommended over SIMV for weaning, because SIMV is inferior in facilitating successful liberation from the ventilator. 38

4. Prophylactic Non‑Invasive Ventilation (NIV) After Extubation

  • For patients identified as high‑risk, applying prophylactic NIV within 1 hour of extubation (initial IPAP 10–12 cm H₂O, EPAP 5–10 cm H₂O) reduces the risk of re‑intubation (RR 0.61; 95 % CI 0.48–0.79), lowers mortality (RR 0.54; 95 % CI 0.41–0.70), and shortens ICU length of stay by roughly 2.5 days. 38

5. Definition and Expected Rates of Extubation Success

  • Extubation is considered successful when the patient does not require re‑intubation or NIV within 48 hours after tube removal. An extubation failure rate of 5–10 % is regarded as acceptable in contemporary practice, and ≈10 % of patients who pass an SBT will still fail extubation. 39

6. Consequences of Extubation Failure

  • Failed extubation is associated with a 10–20 % increase in mortality compared with successful extubation, and up to 15 % of ICU patients require re‑intubation within 48 hours. 39

7. Early Post‑Extubation Complications

  • Post‑extubation stridor occurs in 12–37 % of extubations and accounts for ≈15 % of early re‑intubations, often due to upper‑airway edema. 40

8. Late Post‑Extubation Failure Mechanisms

  • Late extubation failure (beyond 48 hours) is frequently caused by:
    • Capacity‑load imbalance in patients with severe airflow obstruction or neuromuscular weakness,
    • Impaired bulbar function leading to aspiration,
    • Ineffective cough, and
    • Non‑respiratory issues such as myocardial ischemia, left‑ventricular dysfunction, encephalopathy/delirium, or severe abdominal distension. 40

9. Assisted Coughing and Airway Clearance

  • Performing assisted coughing maneuvers (or nasal endotracheal suctioning when needed) during extubation of high‑risk patients improves airway clearance and supports successful extubation. 38

Extubation Assessment and Success Criteria

Upper Airway Patency (Cuff‑Leak Test)

  • In adult ICU patients at risk for laryngeal edema (e.g., female sex, nasal intubation, difficult or traumatic intubation, larger endotracheal tube size, high cuff pressures, or intubation duration > 7 days), a cuff‑leak test should be performed before extubation to evaluate airway patency. 41
  • A cuff‑leak test is considered positive when the leak volume is ≥ 110 mL (absolute) or ≥ 10 % of the tidal volume (relative), indicating sufficient airway opening. 41
  • If the cuff‑leak test is negative (low or absent leak), administer systemic corticosteroids (≈ 1 mg/kg prednisolone) at least 4–6 hours before extubation to reduce the risk of post‑extubation airway edema. 41

Definition of Successful Extubation

  • Successful extubation is defined as no requirement for re‑intubation or non‑invasive ventilation within 48 hours after tube removal; an extubation failure rate of 5–10 % is regarded as acceptable in contemporary ICU practice. 41

REFERENCES

1

T-Piece Spontaneous Breathing Trial Duration and Criteria for Extubation [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Extubation Readiness Assessment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

9

ats/ers statement on respiratory muscle testing. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2002

10

the use of non-invasive ventilation in covid-19: a systematic review. [LINK]

International Journal of Infectious Diseases, 2021

13

ats/ers statement on respiratory muscle testing. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2002

17

ats/ers statement on respiratory muscle testing. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2002

19

ats/ers statement on respiratory muscle testing. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2002

27

airway and lung in sepsis. [LINK]

Intensive Care Medicine, 2001

32

the use of non-invasive ventilation in covid-19: a systematic review. [LINK]

International Journal of Infectious Diseases, 2021

33

the use of non-invasive ventilation in covid-19: a systematic review. [LINK]

International Journal of Infectious Diseases, 2021